Incidence of pulmonary embolism during COPD exacerbation


Akpinar E. E., Hosgun D., Akpinar S., Atac G. K., DOĞANAY ERDOĞAN B., Gulhan M.

JORNAL BRASILEIRO DE PNEUMOLOGIA, cilt.40, sa.1, ss.38-45, 2014 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 40 Sayı: 1
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1590/s1806-37132014000100006
  • Dergi Adı: JORNAL BRASILEIRO DE PNEUMOLOGIA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.38-45
  • Anahtar Kelimeler: Pulmonary disease, chronic obstructive, Pulmonary embolism, Risk factors, DISEASE, PREVALENCE, PATIENT
  • Ankara Üniversitesi Adresli: Evet

Özet

Objective: Because pulmonary embolism (PE) and COPD exacerbation have similar presentations and symptoms, PE can be overlooked in COPD patients. Our objective was to determine the prevalence of PE during COPD exacerbation and to describe the clinical aspects in COPD patients diagnosed with PE. Methods: This was a prospective study conducted at a university hospital in the city of Ankara, Turkey. We included all COPD patients who were hospitalized due to acute exacerbation of COPD between May of 2011 and May of 2013. All patients underwent clinical risk assessment, arterial blood gas analysis, chest CT angiography, and Doppler ultrasonography of the lower extremities. in addition, we measured D-dimer levels and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) levels. Results: We included 172 patients with COPD. The prevalence of PE was 29.1%. The patients with pleuritic chest pain, lower limb asymmetry, and high NT-pro-BNP levels were more likely to develop PE, as were those who were obese or immobile. Obesity and lower limb asymmetry were independent predictors of PE during COPD exacerbation (OR = 4.97; 95% Cl, 1.775-13.931 and OR = 2.329; 95% Cl, 1.127-7.105, respectively). Conclusions: The prevalence of PE in patients with COPD exacerbation was higher than expected. The association between PE and COPD exacerbation should be considered, especially in patients who are immobile or obese.